TGFB2 and prostate carcinoma: Oncomine data revealed elevated TGFβ2 levels in brain, breast, colorectal, oesophageal, gastric, head and neck, renal, liver, pancreatic and lymphoma cancers relative to normal tissue, whereas in certain data sets TGFβ2 levels were lower in brain, breast, kidney, lung and prostate cancer (Figure 1A).